Skip to main content
Top
Published in: Virology Journal 1/2022

Open Access 01-12-2022 | Acute Respiratory Distress-Syndrome | Short report

COVID-19 in Iran: clinical presentations and outcomes in three different surges of COVID-19 infection

Authors: Azar Hadadi, Marzieh Pirzadeh, Sina Kazemian, Haleh Ashraf, Mehdi Ebrahimi, Shahrokh Karbalai Saleh, Mohammad Talebpour

Published in: Virology Journal | Issue 1/2022

Login to get access

Abstract

Background

A few studies compared the characteristics and outcomes of COVID-19 patients during the first and second surges of the disease. We aimed to describe the clinical features and outcomes of COVID-19 patients across the first, second, and third surges of the disease in Tehran, Iran.

Method

We conducted a retrospective cohort study of patients with COVID-19 admitted to Sina hospital in Tehran, Iran, during three surges of COVID-19 from February 16 to October 28, 2020.

Result

Surge 1 patients were younger with more prevalence of hypertension. They also presented with significantly higher oxygen saturation, systolic blood pressure, and respiratory rate on admission. Patients had higher levels of neutrophil to lymphocyte ratio, Urea, CRP, and ESR, in surge 2. The incidence of dyspnea, chest pain, and neurological manifestations followed a significant increasing trend from surge 1 to surge 3. There was no difference in severity and in-hospital mortality between the surges. However, the length of hospital stays and acute cardiac injury (ACI) was less in surge 1 and acute respiratory distress syndrome (ARDS) in surge 2 than in other surges.

Conclusion

Patients did not significantly differ in disease severity, ICU admission, and mortality between surges; however, length of hospital stay and ACI increased during surges, and the number of patients developing ARDS was significantly less in surge 2 compared to other peaks.
Literature
2.
go back to reference Abdi M. Coronavirus disease 2019 (COVID-19) outbreak in Iran: actions and problems. Infect Control Hosp Epidemiol. 2020;41:754–5.CrossRef Abdi M. Coronavirus disease 2019 (COVID-19) outbreak in Iran: actions and problems. Infect Control Hosp Epidemiol. 2020;41:754–5.CrossRef
3.
go back to reference Nikpouraghdam M, Jalali Farahani A, Alishiri G, Heydari S, Ebrahimnia M, Samadinia H, Sepandi M, Jafari NJ, Izadi M, Qazvini A, et al. Epidemiological characteristics of coronavirus disease 2019 (COVID-19) patients in IRAN: a single center study. J Clin Virol. 2020;127: 104378.CrossRef Nikpouraghdam M, Jalali Farahani A, Alishiri G, Heydari S, Ebrahimnia M, Samadinia H, Sepandi M, Jafari NJ, Izadi M, Qazvini A, et al. Epidemiological characteristics of coronavirus disease 2019 (COVID-19) patients in IRAN: a single center study. J Clin Virol. 2020;127: 104378.CrossRef
4.
go back to reference Grasselli G, Zangrillo A, Zanella A, Antonelli M, Cabrini L, Castelli A, Cereda D, Coluccello A, Foti G, Fumagalli R, et al. Baseline characteristics and outcomes of 1591 Patients infected with SARS-CoV-2 admitted to ICUs of the Lombardy region Italy. Jama. 2020;323:1574–81.CrossRef Grasselli G, Zangrillo A, Zanella A, Antonelli M, Cabrini L, Castelli A, Cereda D, Coluccello A, Foti G, Fumagalli R, et al. Baseline characteristics and outcomes of 1591 Patients infected with SARS-CoV-2 admitted to ICUs of the Lombardy region Italy. Jama. 2020;323:1574–81.CrossRef
7.
go back to reference Soleimani A, Kazemian S, Karbalai Saleh S, Aminorroaya A, Shajari Z, Hadadi A, Talebpour M, Sadeghian H, Payandemehr P, Sotoodehnia M, et al. Effects of angiotensin receptor blockers (ARBs) on in-hospital outcomes of patients with hypertension and confirmed or clinically suspected COVID-19. Am J Hypertens. 2020;33:1102–11.CrossRef Soleimani A, Kazemian S, Karbalai Saleh S, Aminorroaya A, Shajari Z, Hadadi A, Talebpour M, Sadeghian H, Payandemehr P, Sotoodehnia M, et al. Effects of angiotensin receptor blockers (ARBs) on in-hospital outcomes of patients with hypertension and confirmed or clinically suspected COVID-19. Am J Hypertens. 2020;33:1102–11.CrossRef
8.
go back to reference Pazoki M, Keykhaei M, Kafan S, Montazeri M, Mirabdolhagh Hazaveh M, Sotoodehnia M, Kazemian S, Talebpour M, Ashraf H, Shariat Moharari R, et al. Risk indicators associated with in-hospital mortality and severity in patients with diabetes mellitus and confirmed or clinically suspected COVID-19. J Diabetes Metab Disord. 2021;20:1–11.CrossRef Pazoki M, Keykhaei M, Kafan S, Montazeri M, Mirabdolhagh Hazaveh M, Sotoodehnia M, Kazemian S, Talebpour M, Ashraf H, Shariat Moharari R, et al. Risk indicators associated with in-hospital mortality and severity in patients with diabetes mellitus and confirmed or clinically suspected COVID-19. J Diabetes Metab Disord. 2021;20:1–11.CrossRef
9.
go back to reference Sheikhi F, Yousefian N, Tehranipoor P, Kowsari Z. Estimation of the basic reproduction number of alpha and delta variants of COVID-19 pandemic in Iran. PLoS ONE. 2022;17: e0265489.CrossRef Sheikhi F, Yousefian N, Tehranipoor P, Kowsari Z. Estimation of the basic reproduction number of alpha and delta variants of COVID-19 pandemic in Iran. PLoS ONE. 2022;17: e0265489.CrossRef
10.
go back to reference Karbalai Saleh S, Oraii A, Soleimani A, Hadadi A, Shajari Z, Montazeri M, Moradi H, Talebpour M, Sadat Naseri A, Balali P, et al. The association between cardiac injury and outcomes in hospitalized patients with COVID-19. Intern Emerg Med. 2020;15:1415–24.CrossRef Karbalai Saleh S, Oraii A, Soleimani A, Hadadi A, Shajari Z, Montazeri M, Moradi H, Talebpour M, Sadat Naseri A, Balali P, et al. The association between cardiac injury and outcomes in hospitalized patients with COVID-19. Intern Emerg Med. 2020;15:1415–24.CrossRef
12.
go back to reference Fluck D, Rankin S, Lewis A, Robin J, Rees J, Finch J, Jones Y, Jones G, Kelly K, Murray P, et al. Comparison of characteristics and outcomes of patients admitted to hospital with COVID-19 during wave 1 and wave 2 of the current pandemic. Intern Emerg Med. 2021;17:1–10. Fluck D, Rankin S, Lewis A, Robin J, Rees J, Finch J, Jones Y, Jones G, Kelly K, Murray P, et al. Comparison of characteristics and outcomes of patients admitted to hospital with COVID-19 during wave 1 and wave 2 of the current pandemic. Intern Emerg Med. 2021;17:1–10.
13.
go back to reference Cummings MJ, Baldwin MR, Abrams D, Jacobson SD, Meyer BJ, Balough EM, Aaron JG, Claassen J, Rabbani LE, Hastie J, et al. Epidemiology, clinical course, and outcomes of critically ill adults with COVID-19 in New York City: a prospective cohort study. Lancet. 2020;395:1763–70.CrossRef Cummings MJ, Baldwin MR, Abrams D, Jacobson SD, Meyer BJ, Balough EM, Aaron JG, Claassen J, Rabbani LE, Hastie J, et al. Epidemiology, clinical course, and outcomes of critically ill adults with COVID-19 in New York City: a prospective cohort study. Lancet. 2020;395:1763–70.CrossRef
14.
go back to reference Caussy C, Pattou F, Wallet F, Simon C, Chalopin S, Telliam C, Mathieu D, Subtil F, Frobert E, Alligier M, et al. Prevalence of obesity among adult inpatients with COVID-19 in France. Lancet Diabetes Endocrinol. 2020;8:562–4.CrossRef Caussy C, Pattou F, Wallet F, Simon C, Chalopin S, Telliam C, Mathieu D, Subtil F, Frobert E, Alligier M, et al. Prevalence of obesity among adult inpatients with COVID-19 in France. Lancet Diabetes Endocrinol. 2020;8:562–4.CrossRef
15.
go back to reference Attaway AH, Scheraga RG, Bhimraj A, Biehl M, Hatipoğlu U. Severe covid-19 pneumonia: pathogenesis and clinical management. BMJ. 2021;372: n436.CrossRef Attaway AH, Scheraga RG, Bhimraj A, Biehl M, Hatipoğlu U. Severe covid-19 pneumonia: pathogenesis and clinical management. BMJ. 2021;372: n436.CrossRef
16.
go back to reference Rahimzadeh H, Kazemian S, Rahbar M, Farrokhpour H, Montazeri M, Kafan S, Salimzadeh A, Talebpour M, Majidi F, Jannatalipour A, Razeghi E. The risk factors and clinical outcomes associated with acute kidney injury in patients with COVID-19: data from a large Cohort in Iran. Kidney Blood Press Res. 2021;46:620–8.CrossRef Rahimzadeh H, Kazemian S, Rahbar M, Farrokhpour H, Montazeri M, Kafan S, Salimzadeh A, Talebpour M, Majidi F, Jannatalipour A, Razeghi E. The risk factors and clinical outcomes associated with acute kidney injury in patients with COVID-19: data from a large Cohort in Iran. Kidney Blood Press Res. 2021;46:620–8.CrossRef
17.
go back to reference Buttenschøn HN, Lynggaard V, Sandbøl SG, Glassou EN, Haagerup A. Comparison of the clinical presentation across two waves of COVID-19: a retrospective cohort study. BMC Infect Dis. 2022;22:423.CrossRef Buttenschøn HN, Lynggaard V, Sandbøl SG, Glassou EN, Haagerup A. Comparison of the clinical presentation across two waves of COVID-19: a retrospective cohort study. BMC Infect Dis. 2022;22:423.CrossRef
18.
go back to reference Vahidy FS, Drews AL, Masud FN, Schwartz RL, Askary BB, Boom ML, Phillips RA. Characteristics and outcomes of COVID-19 patients during initial peak and resurgence in the Houston metropolitan area. JAMA. 2020;324:998–1000.CrossRef Vahidy FS, Drews AL, Masud FN, Schwartz RL, Askary BB, Boom ML, Phillips RA. Characteristics and outcomes of COVID-19 patients during initial peak and resurgence in the Houston metropolitan area. JAMA. 2020;324:998–1000.CrossRef
19.
go back to reference Jalali SF, Ghassemzadeh M, Mouodi S, Javanian M, Akbari Kani M, Ghadimi R, Bijani A. Epidemiologic comparison of the first and second waves of coronavirus disease in Babol, North of Iran. Caspian J Intern Med. 2020;11:544–50.PubMedPubMedCentral Jalali SF, Ghassemzadeh M, Mouodi S, Javanian M, Akbari Kani M, Ghadimi R, Bijani A. Epidemiologic comparison of the first and second waves of coronavirus disease in Babol, North of Iran. Caspian J Intern Med. 2020;11:544–50.PubMedPubMedCentral
20.
go back to reference Mehta OP, Bhandari P, Raut A, Kacimi SEO, Huy NT. Coronavirus disease (COVID-19): comprehensive review of clinical presentation. Front Public Health. 2020;8: 582932.CrossRef Mehta OP, Bhandari P, Raut A, Kacimi SEO, Huy NT. Coronavirus disease (COVID-19): comprehensive review of clinical presentation. Front Public Health. 2020;8: 582932.CrossRef
21.
go back to reference Mousavi SA, Rad S, Rostami T, Rostami M, Mousavi SA, Mirhoseini SA, Kiumarsi A. Hematologic predictors of mortality in hospitalized patients with COVID-19: a comparative study. Hematology. 2020;25:383–8.CrossRef Mousavi SA, Rad S, Rostami T, Rostami M, Mousavi SA, Mirhoseini SA, Kiumarsi A. Hematologic predictors of mortality in hospitalized patients with COVID-19: a comparative study. Hematology. 2020;25:383–8.CrossRef
22.
go back to reference Morell-Garcia D, Ramos-Chavarino D, Bauça JM, Argente Del Castillo P, Ballesteros-Vizoso MA, García de Guadiana-Romualdo L, Gómez-Cobo C, Pou JA, Amezaga-Menéndez R, Alonso-Fernández A, et al. Urine biomarkers for the prediction of mortality in COVID-19 hospitalized patients. Sci Rep. 2021;11:11134.CrossRef Morell-Garcia D, Ramos-Chavarino D, Bauça JM, Argente Del Castillo P, Ballesteros-Vizoso MA, García de Guadiana-Romualdo L, Gómez-Cobo C, Pou JA, Amezaga-Menéndez R, Alonso-Fernández A, et al. Urine biomarkers for the prediction of mortality in COVID-19 hospitalized patients. Sci Rep. 2021;11:11134.CrossRef
23.
go back to reference Mollinedo-Gajate I, Villar-Álvarez F, Zambrano-Chacón M, Núñez-García L, de la Dueña-Muñoz L, López-Chang C, Górgolas M, Cabello A, Sánchez-Pernaute O, Romero-Bueno F, et al. First and second waves of coronavirus disease 2019 in Madrid, Spain: clinical characteristics and hematological risk factors associated with critical/fatal illness. Crit Care Explor. 2021;3: e0346.CrossRef Mollinedo-Gajate I, Villar-Álvarez F, Zambrano-Chacón M, Núñez-García L, de la Dueña-Muñoz L, López-Chang C, Górgolas M, Cabello A, Sánchez-Pernaute O, Romero-Bueno F, et al. First and second waves of coronavirus disease 2019 in Madrid, Spain: clinical characteristics and hematological risk factors associated with critical/fatal illness. Crit Care Explor. 2021;3: e0346.CrossRef
24.
go back to reference He X, Wang L, Wang H, Xie Y, Yu Y, Sun J, Yan J, Du Y, Shen Y, Zeng H. Factors associated with acute cardiac injury and their effects on mortality in patients with COVID-19. Sci Rep. 2020;10:20452.CrossRef He X, Wang L, Wang H, Xie Y, Yu Y, Sun J, Yan J, Du Y, Shen Y, Zeng H. Factors associated with acute cardiac injury and their effects on mortality in patients with COVID-19. Sci Rep. 2020;10:20452.CrossRef
25.
go back to reference Rivara MB, Bajwa EK, Januzzi JL, Gong MN, Thompson BT, Christiani DC. Prognostic significance of elevated cardiac troponin-T levels in acute respiratory distress syndrome patients. PLoS ONE. 2012;7: e40515.CrossRef Rivara MB, Bajwa EK, Januzzi JL, Gong MN, Thompson BT, Christiani DC. Prognostic significance of elevated cardiac troponin-T levels in acute respiratory distress syndrome patients. PLoS ONE. 2012;7: e40515.CrossRef
26.
go back to reference James N, Menzies M, Radchenko P. COVID-19 second wave mortality in Europe and the United States. Chaos. 2021;31: 031105.CrossRef James N, Menzies M, Radchenko P. COVID-19 second wave mortality in Europe and the United States. Chaos. 2021;31: 031105.CrossRef
27.
go back to reference Soriano V, de Mendoza C, Gómez-Gallego F, Corral O, Barreiro P. Third wave of COVID-19 in Madrid Spain. Int J Infect Dis. 2021;107:212–4.CrossRef Soriano V, de Mendoza C, Gómez-Gallego F, Corral O, Barreiro P. Third wave of COVID-19 in Madrid Spain. Int J Infect Dis. 2021;107:212–4.CrossRef
Metadata
Title
COVID-19 in Iran: clinical presentations and outcomes in three different surges of COVID-19 infection
Authors
Azar Hadadi
Marzieh Pirzadeh
Sina Kazemian
Haleh Ashraf
Mehdi Ebrahimi
Shahrokh Karbalai Saleh
Mohammad Talebpour
Publication date
01-12-2022
Publisher
BioMed Central
Published in
Virology Journal / Issue 1/2022
Electronic ISSN: 1743-422X
DOI
https://doi.org/10.1186/s12985-022-01846-7

Other articles of this Issue 1/2022

Virology Journal 1/2022 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.